Skip to main content
Publication date
2019 02 07
Authors
Sardh, E Harper, P Balwani, M Stein, P Rees, D Bissell, DM Desnick, R Parker, C Phillips, J Bonkovsky, HL Vassiliou, D Penz, C Chan-Daniels, A He, QL Querbes, W Fitzgerald, K Kim, JB Garg, P Vaishnaw, A Simon, AR Anderson, KE
Author KI Usernames
Harper, P|pauhar Sardh, E|elsard Vassiliou, D|dapvas
Pubmed ID
30726693
Journal
The New England journal of medicine
Doctype
Article
KI Connection
Hög
Mesh SV
5-aminolevulinatsyntetas Amider Dosrelaterad effekt av läkemedel Injektioner, subkutana Kvinnlig Lever Läkemedelstillförselschema Manlig Medelålders personer Människa Porfobilinogen Porfyri, akut intermittent Riktad molekylär behandling RNA, budbärar RNAi-terapi Vuxna
Mesh EN
5-Aminolevulinate Synthetase Amides Dose-Response Relationship, Drug Drug Administration Schedule Injections, Subcutaneous Liver Molecular Targeted Therapy Porphobilinogen Porphyria, Acute Intermittent RNAi Therapeutics RNA, Messenger
First date
2019-03-02T16:15:16.876Z